2 ms·

Naturally enhanced neutralizing breadth vs. SARS-CoV-2 one year after infection

1 points by dfsegoat 5y ago

dfsegoat 5y ago
> "..data suggest that immunity in [previously infected] individuals will be very long lasting and that [previously infected] individuals who receive available mRNA vaccines will produce antibodies and memory B cells that should be protective against circulating SARS-CoV-2 variants."